Intact Reducing Glycan Promotes the Specific Immune Response to Lacto-N-neotetraose-BSA Neoglycoconjugates
Autor: | Nina Salinger Prasanphanich, Christopher E. Cutler, Xuezheng Song, David F. Smith, Yi Lasanajak, Jamie Heimburg-Molinaro, Anthony Luyai, Richard D. Cummings |
---|---|
Rok vydání: | 2015 |
Předmět: |
Glycan
Biomedical Engineering Oligosaccharides Pharmaceutical Science Bioengineering Article Epitope Mice Immune system Antigen Polysaccharides Animals Tetrasaccharide Bovine serum albumin Glycoproteins Pharmacology Immunity Cellular biology Chemistry Organic Chemistry Bacterial polysaccharide Serum Albumin Bovine Acquired immune system carbohydrates (lipids) Mice Inbred C57BL Biochemistry biology.protein Cattle Female Rabbits Biotechnology |
Zdroj: | Bioconjugate Chemistry. 26:559-571 |
ISSN: | 1520-4812 1043-1802 |
DOI: | 10.1021/acs.bioconjchem.5b00036 |
Popis: | The mammalian immune system responds to eukaryotic glycan antigens during infections, cancer, and autoimmune disorders, but the immunological bases for such responses are unclear. Conjugate vaccines containing bacterial polysaccharides linked to carrier proteins (neoglycoconjugates) have proven successful, but these often contain repeating epitopes and the reducing end of the glycan is less important, unlike typical glycan determinants in eukaryotes, which are shorter in length and may include the reducing end. Here, we have compared the effects of two linkage methods, one that opens the ring at the reducing end of the glycan, and one that leaves the reducing end closed, on the glycan specificity of the vaccine response in rabbits and mice. We immunized rabbits and mice with bovine serum albumin (BSA) conjugates of synthetic open- and closed-ring forms (OR versus CR) of a simple tetrasaccharide lacto-N-neotetraose (LNnT, Galβ1-4GlcNAcβ1-3Galβ1-4Glc), and tested reactivity to the immunogens and several related glycans in both OR and CR versions on glycan microarrays. We found that in rabbits the immune response to the CR conjugate was directed toward the glycan, whereas the OR conjugate elicited antibodies to the reducing end of the glycan and linker region but not specifically to the glycan itself. Unexpectedly, mice did not generate a glycan-specific response to the CR conjugate. Our findings indicate that the reducing end of the sugar is crucial for generation of a glycan-specific response to some eukaryotic vaccine epitopes, and that there are species-specific differences in the ability to make a glycan-specific response to some glycoconjugates. These findings warrant further investigation with regard to rational design of glycoconjugate vaccines. |
Databáze: | OpenAIRE |
Externí odkaz: |